Delivery Order SPE2DE24D0013-SPE2D625F2GZX
- Not listed
- The Defense Logistics Agency's Medical Supply Chain division awarded an $6.8K firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer specializing in infectious disease testing solutions. This delivery order, issued on August 5, 2025, with an ultimate completion date of August 12, 2025, is designated as XPCOV2/FLU/RSV-10 and relates to diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV). The...
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $5,174.64 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, has an ultimate completion date of July 30, 2025, and carries no set-aside designation. The contract references diagnostic testing for COVID-19, influenza, and respiratory syncytial virus (RSV), consistent with...
- The Defense Logistics Agency, under its Medical Supply Chain division, awarded a $13,547.30 firm fixed-price delivery order to Cepheid Inc. on August 14, 2025, for respiratory and influenza diagnostic solutions. The contract, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This delivery order carries no set-aside designation and represents procurement under one of Cepheid's existing federal...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer based in Sunnyvale, California, for COVID-19/Influenza/Respiratory Syncytial Virus testing solutions. The delivery order, designated as XPCOV2/FLU/RSV-10, was executed on August 21, 2025, with an ultimate completion date of August 28, 2025, and carries no set-aside designation. This award represents a continuation of Cepheid's...
- The Defense Logistics Agency's Medical Supply Chain awarded a $30,678.60 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) testing solutions. The contract, which carries no set-aside designation, was executed on August 19, 2025, with an ultimate completion date of August 26, 2025. This delivery order is likely issued under one of Cepheid's existing Indefinite...
- The Defense Logistics Agency awarded a $2,992 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, under contract 4568960202 for COVID-19, influenza, and respiratory syncytial virus (RSV) testing supplies and services. This firm fixed-price delivery order, with no set-aside designation, is scheduled for completion by August 15, 2025, and represents procurement of diagnostic reagents and related testing materials from Cepheid's GeneXpert...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,096.80 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 14, 2025. This firm fixed-price delivery order, designated 4569108553 and titled "XPCOV2/FLU/RSV-10," is scheduled for completion by August 28, 2025, with performance taking place at the contractor's Sunnyvale facility. The award carries no set-aside designation and represents procurement of molecular...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a for-profit molecular diagnostics manufacturer headquartered in Sunnyvale, California, specializes in advanced diagnostic...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2GZXDelivery Order
The Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $25,200 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price contract, designated 4569285129 and titled XPCOV2/FLU/RSV-10, represents delivery of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and is scheduled for completion by September 9, 2025. Performance will take place at Cepheid's facility in Sunnyvale, California. This delivery order likely falls under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Veterans Integrated Service Network, which provide a framework for continuous procurement of molecular diagnostic testing systems, reagents, and assays. Cepheid has established itself as a key federal supplier of point-of-care diagnostic technologies, leveraging its GeneXpert systems and associated test kits across Department of Veterans Affairs networks and Defense Health Agency programs. The relatively modest ceiling value of this delivery order reflects targeted procurement needs for respiratory pathogen testing within the federal healthcare system's broader molecular diagnostics supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.2k | 9/2/25 |